利妥昔单抗  ≥95%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:1mg 5mg 25mg 100mg in glass bottle
产品描述:基本信息 产品编号:R10461 产品名称:Rituximab CAS: 174722-31-7   储存条件 粉末 -20℃ 四年 分子式: C6416H9874N1688O1987S44 溶于液体 -80℃ 六个月 分子量       化学名:      Solubility (25°C)   体外 DMSO   Ethanol   Water   体内(现配现用)     <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 一种抗 CD20 嵌合单克隆抗体,用于某些自身免疫疾病和癌症的研究。 靶点/IC50 CD20   体外研究 Rituximab inhibits the proliferation of stimulated human B cells, which is associated with a relative increase of B cells with an activated naive phenotype. Aside from this population shift, there are no major changes in phenotype or cytokine profile of the various B-cell subsets. B cells stimulated in the presence of rituximab induces stronger T-cell proliferation, compared to B cells stimulated in the absence of rituximab. All lymphoma cells tested are equally sensitive to antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-mediated phagocytosis of tumor cells,and rituximab-induced apoptosis.Rituximab induces high CDC killing of follicular lymphoma cells. 体内研究 A single injection of rituximab or the murine anti-CD20 Ab 1F5, given i.p. 1 day after the tumor, cures 100% of the animals.Depletion of either NK cells or neutrophils or both in tumor-injected animals does not affect the therapeutic activity of the drug. Similarly, rituximab is able to eradicate tumor cells in athymic nude mice, suggesting that its activity is T cell independent.   推荐实验方法(仅供参考) 激酶实验: 生化激酶实验测定IC50和动力学研究 IC50测量使用poly-Glu–Tyr(4:1)或者poly-Lys–Tyr(4:1,针对Lck)为底物。二价阳离子为20mM MgCl2(对于Src、Fyn、Yes、Lyn、Csk、Frk或Abl)或10mM MnCl(对于FGFR1、IGF1R、Lck或Met)。ATP终浓度为:Src,10μM;Fyn,6μM;Yes,100μM;Lyn,2μM;Csk,10μM;Frk,10μM;Abl,4μM;FGFR1,10μM;IGF1R,2μM;Lck,2μM;Met,5μM;PDGFR,6μM。PDGFRb的磷酸化IC50值是通过测量免疫沉淀的PDGFRb确定的。Km值使用Eadie-Hofstee法计算。   细胞实验:   A single injection of rituximab or the murine anti-CD20 Ab 1F5, given i.p. 1 day after the tumor,cures 100% of the animals.Depletion of either NK cells or neutrophils or both in tumor-injected animals does not affect the therapeutic activity of the drug. Similarly, rituximab is able to eradicate tumor cells in athymic nude mice, suggesting that its activity is T cell independent.   动物实验:   C57BL/6 mice (8-10 wk of age) are inoculated 8×103 EL4-CD20+cells in 200μL of saline by tail vein injection. In parallel groups of mice,150g of rituximab, murine anti-CD20 IgG2a Ab 1F5, or control anti-human IL-2R Ab daclizumab in 300μL of saline, or saline only is inoculated i.p. 24h later.
保存条件:-20℃